Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Carbaglu granted fast track designation for NAGS deficiency

July 12, 2007

Akesis files pre-IND for AKP-020

July 12, 2007

Oleoyl-estrone discontinued for common obesity and morbid obesity

July 12, 2007

Positive phase Ib/II data for PBI-402 in anemia prompts ProMetic to file trial expansion

July 12, 2007

U.S. orphan drug designation for Corlux in Cushing's syndrome

July 11, 2007

Update on Karo Bio and Merck collaboration

July 11, 2007

CV Therapeutics identifies potential first-in-class MOA for ranolazine

July 11, 2007

NPS and Nycomed expand Preotact agreement

July 11, 2007

Biologics Menoflavon launched in Canada

July 11, 2007

Summary of studies evaluating the effect of various natural products on diabetes

July 11, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...